文献速递心血管US

肺静脉波形预测经皮二尖瓣修复术后再住院与死亡

Pulmonary Venous Waveforms Predict Rehospitalization and Mortality After Percutaneous Mitral Valve Repair.
PubMed 文献 · JACC Cardiovasc Imaging · 2018-09-12

回顾性分析115例因二尖瓣反流接受MitraClip经皮二尖瓣修复术患者的术中经食管超声与有创血流动力学资料,93例肺静脉波形可用于分析,其中67例(73%)术中肺静脉形态改善。肺静脉改善组24个月生存57例(85%),未改善组仅10例(40%),多因素分析显示肺静脉改善预测1年心脏再住院减少(OR 0.18,P=0.044)。

要点

  • 术中肺静脉波形形态改善与经皮二尖瓣修复术后生存改善相关(HR 0.28,95%CI 0.08–0.93,P=0.038)。
  • 肺静脉改善组24个月生存57例(85%),未改善组10例(40%)。
  • 术中二尖瓣反流分级与有创血流动力学未持续预测死亡与再住院。

核心结论

  • 肺静脉波形是经皮二尖瓣修复术后手术成功的重要标志,术中肺静脉波形可能预测术后再住院与死亡。

研究设计与样本

  • 回顾性研究,纳入2013年5月至2017年1月在Emory大学医院因二尖瓣反流接受MitraClip经皮二尖瓣修复术的115例连续患者(年龄76±12岁),回顾病历与术中经食管超声心动图。

关键影像表现/征象

  • 93例(80%)在夹合器置入前后有可用于分析的肺静脉波形。
  • 93例中67例(73%)术中肺静脉形态改善,25例(27%)未改善。
  • 术中评估的二尖瓣反流分级与有创血流动力学未持续预测死亡和再住院。

诊断标准与关键数值

  • 以术中经食管超声评估肺静脉波形形态是否改善进行分组。
  • 肺静脉改善组与未改善组比较:24个月生存57例(85%)vs 10例(40%)。
  • 肺静脉改善组生存优势:HR 0.28(95%CI 0.08–0.93,P=0.038)。
  • 多因素分析:肺静脉改善预测1年心脏再住院减少,OR 0.18(P=0.044)。

局限性

  • 原文为回顾性研究。
  • 原文指出需要更大规模的多中心队列来阐明该关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: In this study, the authors hypothesized that intraprocedural improvement of pulmonary venous (PV) waveforms are predictive of improved outcomes. In this report, they analyzed intraprocedural invasive and echocardiographic changes with respect to rehospitalization and mortality.

BACKGROUND: The effects of hemodynamic changes during percutaneous mitral valve repair (PMVR) with MitraClip (Abbott Vascular, Santa Clara, California) are incompletely characterized.

METHODS: The authors retrospectively reviewed records and intraprocedural transesophageal echocardiograms of 115 consecutive patients (age 76 ± 12 years) who underwent PMVR for mitral regurgitation (MR) from May 2013 to January 2017 at Emory University Hospital. They assessed intraprocedural PV waveforms for improvement in morphology, measured change in MR grade by semiquantitative methods, evaluated invasive changes in left atrial pressure (LAP) and V-wave, and compared with 30-day and 1-year rehospitalization and all-cause mortality.

RESULTS: Ninety-three cases (80%) had PV waveforms before and after clip placement sufficient for analysis, of which 67 (73%) demonstrated intraprocedural improvement in PV morphology and 25 (27%) did not. At 24 months, 57 (85%) of those with PV improvement were living, compared with only 10 (40%) of those without improvement. Proportional hazards models demonstrated a significant survival advantage in those with PV improvement (hazard ratio [HR]: 0.28, 95% confidence interval [CI]: 0.08 to 0.93, p = 0.038). By multivariable analysis, PV improvement predicted reduced 1-year cardiac rehospitalization (odds ratio [OR]: 0.18, p = 0.044). Intraprocedural assessment of MR grade and invasive hemodynamics did not consistently predict mortality and rehospitalization.

CONCLUSIONS: PV waveforms are important markers of procedural success after PMVR. Our data show intraprocedural PV waveforms may predict rehospitalization and mortality after PMVR. A larger, multicenter cohort will be important to clarify this relationship.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Corrigan FE, Chen JH, Maini A, et al. Pulmonary Venous Waveforms Predict Rehospitalization and Mortality After Percutaneous Mitral Valve Repair. JACC Cardiovasc Imaging. 2018. PMID: 30219407. doi:10.1016/j.jcmg.2018.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。